Olin OLN
$15.19 −$1.09 (-6.70%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $15.37 +1.18%
Open$16.28
Prev close$16.28
Day range$15.15 – $16.51
Volume2.83M
Market cap$1.73B
P/E (TTM)–
Dividend yield5.27%
OLN Stock News
Headlines matching Olin or the OLN ticker, most recent first.
- Goldman Sachs Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $18 Negative
- Citi Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $17 Negative
- Mizuho Securities Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $21 Negative
- Citi Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $19 Negative
- J.P. Morgan Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $19 Negative
- Goldman Sachs Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $20 Negative
- Wells Fargo Downgrades Olin(OLN.US) to Hold Rating, Cuts Target Price to $20 Negative
- RBC Capital Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $20 Negative
- BofA Securities Downgrades Olin(OLN.US) to Sell Rating Negative
- Truist Financial Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $20 Negative
- UBS Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $21 Negative
- Olin | 8-K: Current report
- Deutsche Bank Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $20 Negative
- Olin | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
- Chengdu Olymvax Biopharmaceuticals Inc: Annual Report Summary 2025 of Chengdu Olin Bio-Tech Co., Ltd.
No comments yet — be the first to weigh in on OLN.
Sign in to join the discussion.